This report analyzes the business environment of GlaxoSmithKline (GSK) and AstraZeneca (AZ), focusing on the purposes of these organizations compared to others like the NHS and Red Cross. It delves into internal and external factors impacting GSK, including fiscal and monetary policies, and the effects of UK and EU regulations. The report examines stakeholder relationships, including employees, consumers, suppliers, and shareholders, and explores GSK's responsibilities. Furthermore, it discusses economic systems, market structures, and the significance of international trade to both GSK and AZ, along with the influence of global factors and European Union policies on their activities. The analysis covers topics such as competition, pricing decisions, and the impact of the business and cultural environments on GSK's behavior, providing a comprehensive overview of the pharmaceutical industry's operational landscape.
![[object Object]](/_next/static/media/star-bottom.7253800d.svg)
